» Authors » Francisco Bosques-Padilla

Francisco Bosques-Padilla

Explore the profile of Francisco Bosques-Padilla including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 898
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu C, Wang L, Maestri E, Jacob A, Do W, Mayo S, et al.
Hepatology . 2024 Sep; PMID: 39325984
Background And Aims: Alcohol-associated hepatitis (AH) is associated with very high mortality despite abstinence from alcohol; up to 40% of patients die within 6 months of diagnosis. Patients with AH...
2.
Guillen Graf A, Reyna Arechiga A, Escareno Perez C, Bosques-Padilla F, Jaquez Quintana J
Rev Esp Enferm Dig . 2024 Sep; PMID: 39267489
Biliary tract complications after orthotopic liver transplantation (OLT) are frequently reported. The diagnosis and management of these complications have become increasingly crucial, with digital single operator cholangioscopy (DSOC) emerging as...
3.
Kreimeyer H, Gonzalez C, Fondevila M, Hsu C, Hartmann P, Zhang X, et al.
Gut . 2024 Jul; 74(1):103-115. PMID: 39033024
Objective: Patients with alcohol-associated hepatitis (AH) have a high mortality. Alcohol exacerbates liver damage by inducing gut dysbiosis, bacterial translocation and inflammation, which is characterised by increased numbers of circulating...
4.
Yamazaki T, Kouno T, Hsu C, Hartmann P, Mayo S, Zhang X, et al.
Hepatology . 2024 Feb; 80(2):403-417. PMID: 38377466
Background And Aims: Patients with alcohol-associated hepatitis (AH) have an altered fecal metabolome, including reduced microbiota-derived tryptophan metabolites, which function as ligands for aryl hydrocarbon receptor (AhR). The aim of...
5.
Jimenez C, Ventura-Cots M, Sala M, Calafat M, Garcia-Retortillo M, Cirera I, et al.
Liver Int . 2022 Feb; 42(5):1109-1120. PMID: 35220659
Background & Aims: Alcoholic hepatitis (AH) is associated with a high incidence of infection and mortality. Rifaximin reduces bacterial overgrowth and translocation. We aimed to study whether the administration of...
6.
Yamamoto-Furusho J, Parra-Holguin N, Juliao-Banos F, Puentes F, Lopez R, Bosques-Padilla F, et al.
Medicine (Baltimore) . 2022 Jan; 101(3):e28624. PMID: 35060539
The aim of the present study was to describe the epidemiological and clinical characteristics of inflammatory bowel disease (IBD), including medical and surgical treatments, in several countries in Latin America...
7.
Musto J, Eickhoff J, Ventura-Cots M, Abraldes J, Bosques-Padilla F, Verna E, et al.
Liver Transpl . 2021 Jun; 27(10):1382-1391. PMID: 34109723
The 10-item Alcohol Use Disorders Identification Test (AUDIT-10) and its shorter form, AUDIT-Consumption (AUDIT-C), are questionnaires used to characterize severity of drinking. We hypothesized that liver injury and short-term outcomes...
8.
Parker R, Cabezas J, Altamirano J, Arab J, Ventura-Cots M, Sinha A, et al.
Clin Gastroenterol Hepatol . 2021 Jan; 20(2):e289-e297. PMID: 33516950
Background And Aims: Alcoholic hepatitis (AH) is a severe condition with poor short-term prognosis. Specific treatment with corticosteroids slightly improves short-term survival but is associated with infection and is not...
9.
Poo J, Torre A, Aguilar-Ramirez J, Cruz M, Mejia-Cuan L, Cerda E, et al.
Hepatol Int . 2020 Aug; 14(5):817-827. PMID: 32813194
Background And Aims: Pirfenidone (PFD), an oral antifibrotic drug, has been authorized by the EMA and FDA for treatment of idiopathic pulmonary fibrosis. Few studies have addressed its use in...
10.
Jiang L, Lang S, Duan Y, Zhang X, Gao B, Chopyk J, et al.
Hepatology . 2020 Jul; 72(6):2182-2196. PMID: 32654263
Background And Aims: Alcoholic hepatitis (AH) is a severe manifestation of alcohol-associated liver disease (ALD) with high mortality. Although gut bacteria and fungi modulate disease severity, little is known about...